New Emirates Medical Journal

New Emirates Medical Journal

Editor-in-Chief

ISSN (Print): 0250-6882
ISSN (Online): 0250-6882

Research Article

Echocardiographic Features of Cardiac Amyloidosis: Insights from a Case Series

Author(s): Mohammed Alghamdi*orcid of author, Hatim Kheirallah, Khalid Alkhalifaorcid of author and Khalid Alanazi

Volume 5, 2024

Published on: 20 May, 2025

Article ID: e02506882349552

Pages: 5

DOI: 10.2174/0102506882349552250407102903

open_access

Abstract

Introduction: Cardiac amyloidosis, characterized by amyloid fibril deposition in the heart, often leads to heart failure and has a high mortality rate. The early detection of cardiac amyloidosis is critical for improving patient prognosis; however, the subtle and variable presentations of this condition can make early diagnosis challenging. Echocardiography is pivotal for diagnosing this condition. Through this study, we aim to improve the understanding of the echocardiographic features of cardiac amyloidosis.

Methods: This retrospective case series was based on the data of patients diagnosed with amyloid transthyretin-related cardiac amyloidosis (ATTR cardiac amyloidosis) from 2020 to 2024 at the Prince Sultan Cardiac Center in Riyadh, Saudi Arabia. The collected data included demographic characteristics, medical history, laboratory results, medication use, 12-lead electrocardiography results, and echocardiographic parameters.

Results: Fifteen patients (11 males and four females, aged 41–88 years) were included in the analysis. The most common comorbidities were hypertension (seven patients) and atrial fibrillation (nine patients). The key echocardiographic characteristics were increased left ventricular (LV) wall thickness (mean: 19.9 mm), reduced global longitudinal strain (mean: −10%), and apical sparing. Six patients were positive for the 5-5-5 sign and pericardial effusion.

Conclusion: Recognizing echocardiographic features, such as apical sparing and increased LV wall thickness, is essential for the early diagnosis of cardiac amyloidosis. Improved clinical awareness and diagnostic protocols could enhance early detection and patient outcomes.

Keywords: Echocardiographic feature, Cardiac amyloidosis, Pericardial effusion, LV wall thickness, Amyloid fibrils.

[1]
Ruberg, F.L.; Berk, J.L. Transthyretin (TTR) cardiac amyloidosis. Circulation, 2012, 126(10), 1286-1300.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.078915] [PMID: 22949539]
[2]
Martinez-Naharro, A.; Hawkins, P.N.; Fontana, M. Cardiac amyloidosis. Clin. Med., 2018, 18(2), s30-s35.
[http://dx.doi.org/10.7861/clinmedicine.18-2-s30] [PMID: 29700090]
[3]
Wechalekar, A.D.; Gillmore, J.D.; Hawkins, P.N. Systemic amyloidosis. Lancet, 2016, 387(10038), 2641-2654.
[http://dx.doi.org/10.1016/S0140-6736(15)01274-X] [PMID: 26719234]
[4]
Bellavia, D.; Pellikka, P.A.; Abraham, T.P.; Al-Zahrani, G.B. Detection of left ventricular thickening in cardiac amyloidosis. J. Am. Soc. Echocardiogr., 2008, 21(7), 824-831.
[PMID: 18222635]
[5]
Kittleson, M.M.; Maurer, M.S.; Ambardekar, A.V.; Bullock-Palmer, R.P.; Chang, P.P.; Eisen, H.J.; Nair, A.P.; Nativi-Nicolau, J.; Ruberg, F.L. Cardiac amyloidosis: Evolving diagnosis and management: A scientific statement from the american heart association. Circulation, 2020, 142(1), e7-e22.
[http://dx.doi.org/10.1161/CIR.0000000000000792] [PMID: 32476490]
[6]
Phelan, D.; Collier, P.; Thavendiranathan, P.; Popović, Z.B.; Hanna, M.; Plana, J.C.; Marwick, T.H.; Thomas, J.D. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart, 2012, 98(19), 1442-1448.
[http://dx.doi.org/10.1136/heartjnl-2012-302353] [PMID: 22865865]
[7]
Sperry, B.W.; Ikram, A.; Hachamovitch, R.; Valent, J.; Vranian, M.N.; Phelan, D.; Hanna, M. Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure. J. Am. Coll. Cardiol., 2016, 67(25), 2941-2948.
[http://dx.doi.org/10.1016/j.jacc.2016.03.593] [PMID: 27339491]
[8]
Falk, R.H.; Alexander, K.M.; Liao, R.; Dorbala, S. AL (light-chain) cardiac amyloidosis. J. Am. Coll. Cardiol., 2016, 68(12), 1323-1341.
[http://dx.doi.org/10.1016/j.jacc.2016.06.053] [PMID: 27634125]
[9]
Banypersad, S.M.; Moon, J.C.; Whelan, C.; Hawkins, P.N.; Wechalekar, A.D. Updates in cardiac amyloidosis: A review. J. Am. Heart Assoc., 2012, 1(2), e000364.
[http://dx.doi.org/10.1161/JAHA.111.000364] [PMID: 23130126]
[10]
Maurer, M.S.; Bokhari, S.; Damy, T.; Dorbala, S.; Drachman, B.M.; Fontana, M.; Grogan, M.; Kristen, A.V.; Lousada, I.; Nativi-Nicolau, J.; Cristina Quarta, C.; Rapezzi, C.; Ruberg, F.L.; Witteles, R.; Merlini, G. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ. Heart Fail., 2019, 12(9), e006075.
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006075] [PMID: 31480867]
[11]
González-López, E.; Gallego-Delgado, M.; Guzzo-Merello, G.; de Haro-del Moral, F.J.; Cobo-Marcos, M.; Robles, C.; Bornstein, B.; Salas, C.; Lara-Pezzi, E.; Alonso-Pulpon, L.; Garcia-Pavia, P. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur. Heart J., 2015, 36(38), 2585-2594.
[http://dx.doi.org/10.1093/eurheartj/ehv338] [PMID: 26224076]
[12]
Maurer, M.S.; Elliott, P.; Comenzo, R.; Semigran, M.; Rapezzi, C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation, 2017, 135(14), 1357-1377.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024438] [PMID: 28373528]
[13]
Sperry, B.W.; Soman, P.; Gorcsan, J. Echocardiographic findings in light chain cardiac amyloidosis. JACC Cardiovasc. Imaging, 2016, 9(5), 616-620.
[14]
Grogan, M.; Dispenzieri, A.; Kyle, R.A. Natural history and therapy of al amyloidosis in 232 patients over two decades. J. Am. Coll. Cardiol., 2012, 45(3), 1585-1590.
[15]
Benson, M.D.; Kincaid, J.C. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve, 2007, 36(4), 411-423.
[http://dx.doi.org/10.1002/mus.20821] [PMID: 17554795]